Zenome

Zenome

Created using Figma
Created using Figma
Zenome is a decentralized blockchain-driven database of genomic data. This platform supports the chance to handle your genomic information while maintaining retirement and capacity to construct a profit from selling access to different parts of the genome. Zenome is a new financial environment based on genomic information and blockchain technology.
Sep 3, 2018
Sep 17, 2018
100% completed
Raised funds - no Data
116
Cap 350 000.00 USD
Hard cap 1 150 000.00 USD
past
  • 1 ZNA
    =
    1 USD
Oct, 2017
Nov, 2017
100% completed
$662 000
116
hard cap
cap
66% cap completed
Cap 1 000 000.00 USD
Hard cap 100 000 000.00 USD
past
  • 1 ZNA
    =
    0.6 USD
Token Details
Ticker
ZNA
Accepted Currencies
ETH, BTC
Company Details
Registered Country
Russia
Additional Details
Platform
Ethereum
KYC
Yes
Categories
Platform, Health, Software, Artificial Intelligence

About Zenome

It appears that the exchange of genetic information is of crucial importance. The prospective genetic market must ensure protection from possible misuse and genetic discrimination in particular. It is particularly important to maintain transparency and equal access to this market.

Zenome aims at creating the personal genomics infrastructure, that would enable participants to:

  • Upload genetic information and take control of it.
  • Securely store own genetic information.
  • Make profit by selling access to genetic data or part of it.
  • Undergo genetic testing in exchange to the right to use genetic information.
  • Get individual dietary recommendations or personal training program based on genetic makeup.
  • Make use of other genetic services.

The principal customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.

Inside Zenome Platform different types of information are inextricably intertwined. The nature of each type determines the way to store information of that kind.

  • Financial data, which includes records of transactions, is stored on blockchain.
  • Anonymized genomic data is stored on the distributed network.
  • Participant's personal data is kept on their own computers only.

Treating data of different kind differently provides privacy as well as scalability of the system.

Since all data transactions, including buying and selling data, are governed by smart-contracts, interactions can only include balances stored on blockchains.

Using any of pre-existing tokens for this purpose would result in unreasonable dependence on the valuation of external token. Thus, a separate utility token should be issued to power economic interactions on the platform.

Features

  • Decentralized platform
  • Suitable for non-human organisms
  • Customer is the owner of his data
  • Opened nonprivate data
  • Performs its own data analysis
  • Provides a report for customers
  • Uses AI and Machine Learning
  • Sharing without transmitting huge data
  • Users can earn using their data
  • Opened for scientists

Zenome Roadmap

  • Development of MVP - IT - DEC 2017

  • Development of web-interface capable of uploading genetic data to the network and providing personalized genetic report.
    The first service provider on the Zenome platform.
  • Pilot - MAR 2018

  • The establishment of a network for distributed storing of genetic information.
    Development of a client application capable of uploading genetic data from user's PC.
  • B-version - MAY 2018

  • Using smart-contacts to enforce operations with genetic data: buying, selling, transferring.
  • Fund Zenome - JUN 2018

  • The establishment of Zenome Fund to support projects based on a platform.
    The Main Committee of Zenome Fund would be established.
  • Read More
  • Lab partnership - SEP 2018

  • The establishment of a broad network of partnerships with genetic labs.
    Collecting genetic material and adding these DNA samples to the network.
    Achieve the size of 2 000 000 active users.
  • Creation of the Market - DEC 2018

  • Commercialization.
    The start of the active genetic data exchange between the users.
  • Big Pharma partnership - MAR 2019

  • Reach a partnership agreement with Big Pharma.
    Start developing personalized drugs based on the genetic data collected.
  • FMCG partnership - AUG 2019

  • Reach a partnership agreement with leading FMCG-companies.
    Start developing personalized nutrition based on the genetic data collected.

Activity

Activity:
156
MEDIUM
Posts:
135
LOW
Views:
6 231
MEDIUM
Activity:
156
MEDIUM
Merit:
10
LOW
Posts:
95
VERY LOW
Views:
3 370
LOW
Users:
24
LOW
Posts:
364
HIGH
Followers:
2 150
MEDIUM
Likes:
2 051
MEDIUM
Followers:
1 263
LOW
Tweets:
1 027
VERY HIGH
30 Days Growth:
Members:
615
LOW
30 Days Growth:
-25

Zenome Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Alexey Gorbachev
Ph.D. in molecular biology and biochemistry
unverified
Nikolay Kulemin
Ph.D. in bioinformatics
unverified

2 ICO

$662 000

Vladimir Naumov
Genomic data scientist
unverified
Sergey Popov
Developer
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Dmitry Kwon
Advisor
unverified

Zenome Last News

$ 0.2212
Coin Stats
Daily, %:
Weekly, %:
Monthly, %:
Market Info
Market Cap:
Volume 24h:
$ 663.58
Circ. Supply:
0 ZNA
Ticker:
ZNA
ICO profit
X 0.2765
ICO Price~$0.8000
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.
Planning an ICO? We can help with a wide range of support for all stages of your ICO